Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aneuploidy | 9 | 2023 | 540 | 1.390 |
Why?
|
| Fertilization in Vitro | 16 | 2023 | 1294 | 1.300 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 2 | 2018 | 57 | 1.190 |
Why?
|
| Abortion, Spontaneous | 6 | 2023 | 546 | 1.010 |
Why?
|
| Blastocyst | 7 | 2023 | 431 | 1.000 |
Why?
|
| Reproductive Techniques, Assisted | 10 | 2023 | 490 | 0.960 |
Why?
|
| Preimplantation Diagnosis | 5 | 2023 | 148 | 0.880 |
Why?
|
| Live Birth | 11 | 2023 | 520 | 0.880 |
Why?
|
| Infertility | 5 | 2024 | 657 | 0.870 |
Why?
|
| Embryo Implantation | 4 | 2023 | 278 | 0.840 |
Why?
|
| Nuchal Translucency Measurement | 3 | 2019 | 59 | 0.740 |
Why?
|
| Pregnancy Rate | 14 | 2023 | 652 | 0.720 |
Why?
|
| Premature Birth | 5 | 2023 | 1764 | 0.690 |
Why?
|
| Embryo Transfer | 9 | 2022 | 514 | 0.690 |
Why?
|
| Chromosome Disorders | 2 | 2023 | 512 | 0.630 |
Why?
|
| Down Syndrome | 3 | 2023 | 903 | 0.600 |
Why?
|
| Prenatal Diagnosis | 4 | 2023 | 1242 | 0.570 |
Why?
|
| Birth Rate | 6 | 2023 | 174 | 0.570 |
Why?
|
| Chorionic Gonadotropin | 2 | 2023 | 479 | 0.530 |
Why?
|
| Oocytes | 5 | 2023 | 1193 | 0.500 |
Why?
|
| Ontario | 9 | 2023 | 386 | 0.480 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 1236 | 0.470 |
Why?
|
| Genetic Testing | 5 | 2022 | 3487 | 0.460 |
Why?
|
| Diabetes, Gestational | 1 | 2023 | 1202 | 0.460 |
Why?
|
| Pregnancy | 35 | 2023 | 29630 | 0.460 |
Why?
|
| Sperm Injections, Intracytoplasmic | 3 | 2023 | 163 | 0.460 |
Why?
|
| Pregnancy Outcome | 9 | 2023 | 2854 | 0.440 |
Why?
|
| Maternal Age | 4 | 2019 | 810 | 0.440 |
Why?
|
| Cryopreservation | 3 | 2023 | 696 | 0.430 |
Why?
|
| Semen | 4 | 2023 | 344 | 0.430 |
Why?
|
| Pregnancy Complications | 5 | 2022 | 2899 | 0.350 |
Why?
|
| Progesterone | 2 | 2023 | 779 | 0.310 |
Why?
|
| Oocyte Retrieval | 3 | 2022 | 161 | 0.290 |
Why?
|
| Fertility | 2 | 2022 | 783 | 0.240 |
Why?
|
| Cumulus Cells | 1 | 2023 | 21 | 0.230 |
Why?
|
| Pregnancy Trimester, First | 2 | 2018 | 880 | 0.220 |
Why?
|
| Retrospective Studies | 26 | 2023 | 78758 | 0.220 |
Why?
|
| Vitrification | 1 | 2023 | 60 | 0.220 |
Why?
|
| Uterine Diseases | 1 | 2023 | 134 | 0.210 |
Why?
|
| Leuprolide | 1 | 2023 | 322 | 0.200 |
Why?
|
| Ovulation Induction | 1 | 2023 | 276 | 0.190 |
Why?
|
| Insurance | 1 | 2022 | 113 | 0.190 |
Why?
|
| alpha-Fetoproteins | 2 | 2023 | 225 | 0.190 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2020 | 25 | 0.190 |
Why?
|
| Embryo Culture Techniques | 1 | 2021 | 84 | 0.180 |
Why?
|
| Nitrogen Mustard Compounds | 1 | 2020 | 45 | 0.180 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2023 | 737 | 0.180 |
Why?
|
| Erectile Dysfunction | 1 | 2023 | 462 | 0.170 |
Why?
|
| Female | 41 | 2023 | 385090 | 0.170 |
Why?
|
| Nifedipine | 1 | 2019 | 225 | 0.170 |
Why?
|
| Ovarian Follicle | 2 | 2022 | 248 | 0.160 |
Why?
|
| Endocrinology | 1 | 2024 | 443 | 0.150 |
Why?
|
| Estriol | 1 | 2016 | 53 | 0.140 |
Why?
|
| State Government | 1 | 2019 | 373 | 0.140 |
Why?
|
| Infant, Newborn | 8 | 2023 | 25903 | 0.140 |
Why?
|
| Financing, Government | 1 | 2019 | 466 | 0.140 |
Why?
|
| Eligibility Determination | 1 | 2019 | 409 | 0.130 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2020 | 382 | 0.130 |
Why?
|
| Inhibins | 1 | 2016 | 214 | 0.130 |
Why?
|
| Insemination, Artificial, Heterologous | 1 | 2015 | 10 | 0.130 |
Why?
|
| Birth Weight | 1 | 2023 | 2099 | 0.130 |
Why?
|
| Azoospermia | 1 | 2015 | 27 | 0.130 |
Why?
|
| Pregnancy, Multiple | 3 | 2023 | 218 | 0.130 |
Why?
|
| Single Embryo Transfer | 1 | 2014 | 29 | 0.120 |
Why?
|
| Chromosome Aberrations | 1 | 2021 | 1806 | 0.120 |
Why?
|
| Humans | 42 | 2024 | 752741 | 0.120 |
Why?
|
| Adult | 22 | 2024 | 216658 | 0.120 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2019 | 500 | 0.110 |
Why?
|
| Cannabis | 1 | 2020 | 438 | 0.110 |
Why?
|
| Labor, Induced | 1 | 2014 | 160 | 0.110 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 15164 | 0.110 |
Why?
|
| Cesarean Section | 2 | 2018 | 1428 | 0.110 |
Why?
|
| Obesity | 3 | 2023 | 12868 | 0.100 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 6624 | 0.090 |
Why?
|
| Young Adult | 12 | 2024 | 57267 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 2083 | 0.090 |
Why?
|
| Body Mass Index | 3 | 2023 | 12821 | 0.090 |
Why?
|
| Self Report | 1 | 2020 | 3618 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2019 | 2295 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3374 | 0.080 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 7852 | 0.080 |
Why?
|
| Insurance, Health | 1 | 2020 | 2501 | 0.080 |
Why?
|
| Apgar Score | 1 | 2018 | 126 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 5410 | 0.080 |
Why?
|
| Registries | 2 | 2022 | 8216 | 0.070 |
Why?
|
| Canada | 3 | 2022 | 2081 | 0.070 |
Why?
|
| Fetal Death | 1 | 2018 | 449 | 0.070 |
Why?
|
| Cohort Studies | 4 | 2022 | 40939 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 3966 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2015 | 2618 | 0.060 |
Why?
|
| Postpartum Hemorrhage | 1 | 2018 | 273 | 0.060 |
Why?
|
| Fetal Growth Retardation | 1 | 2018 | 583 | 0.060 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2023 | 74 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 4638 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5222 | 0.060 |
Why?
|
| Insemination | 1 | 2022 | 19 | 0.060 |
Why?
|
| Alkylating Agents | 1 | 2023 | 139 | 0.060 |
Why?
|
| Hysteroscopy | 1 | 2023 | 97 | 0.050 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2023 | 115 | 0.050 |
Why?
|
| Follicular Phase | 1 | 2023 | 149 | 0.050 |
Why?
|
| Adolescent | 8 | 2024 | 86713 | 0.050 |
Why?
|
| Sperm Motility | 1 | 2023 | 269 | 0.050 |
Why?
|
| Tissue Adhesions | 1 | 2023 | 233 | 0.050 |
Why?
|
| Insemination, Artificial | 1 | 2022 | 98 | 0.050 |
Why?
|
| Oogenesis | 1 | 2022 | 132 | 0.050 |
Why?
|
| Cytogenetic Analysis | 1 | 2023 | 286 | 0.050 |
Why?
|
| Uterine Hemorrhage | 1 | 2023 | 259 | 0.050 |
Why?
|
| Breast Feeding | 1 | 2010 | 1335 | 0.050 |
Why?
|
| Trisomy | 1 | 2023 | 265 | 0.050 |
Why?
|
| Ploidies | 1 | 2021 | 282 | 0.050 |
Why?
|
| Educational Status | 2 | 2024 | 2573 | 0.050 |
Why?
|
| Endometrium | 1 | 2022 | 422 | 0.040 |
Why?
|
| Sperm Count | 1 | 2020 | 229 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2023 | 1346 | 0.040 |
Why?
|
| Culture Media | 1 | 2021 | 908 | 0.040 |
Why?
|
| Family Planning Services | 1 | 2022 | 267 | 0.040 |
Why?
|
| Infant | 4 | 2023 | 35447 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2023 | 856 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20026 | 0.040 |
Why?
|
| Prolactin | 1 | 2020 | 673 | 0.040 |
Why?
|
| Semen Analysis | 1 | 2020 | 235 | 0.040 |
Why?
|
| Luteinizing Hormone | 1 | 2020 | 868 | 0.040 |
Why?
|
| Cannabinoids | 1 | 2020 | 170 | 0.040 |
Why?
|
| Pregnant Women | 1 | 2022 | 576 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2022 | 64017 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2020 | 715 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2023 | 2987 | 0.030 |
Why?
|
| Ovary | 1 | 2020 | 983 | 0.030 |
Why?
|
| Ovarian Function Tests | 1 | 2015 | 11 | 0.030 |
Why?
|
| Hypertension | 1 | 2015 | 8614 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2021 | 1687 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2022 | 1106 | 0.030 |
Why?
|
| Estradiol | 1 | 2022 | 2025 | 0.030 |
Why?
|
| Counseling | 1 | 2022 | 1535 | 0.030 |
Why?
|
| Cardiotocography | 1 | 2014 | 23 | 0.030 |
Why?
|
| Middle Aged | 6 | 2024 | 216054 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 21976 | 0.030 |
Why?
|
| Male | 5 | 2023 | 354311 | 0.030 |
Why?
|
| Fetus | 1 | 2021 | 1889 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 20914 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2023 | 2060 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2021 | 3493 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2021 | 2502 | 0.030 |
Why?
|
| Urban Population | 1 | 2020 | 2031 | 0.030 |
Why?
|
| Gestational Age | 1 | 2021 | 3555 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2023 | 2863 | 0.020 |
Why?
|
| Child | 3 | 2023 | 78594 | 0.020 |
Why?
|
| Biopsy | 1 | 2022 | 6771 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2775 | 0.020 |
Why?
|
| Home Childbirth | 1 | 2010 | 55 | 0.020 |
Why?
|
| Testosterone | 1 | 2020 | 2457 | 0.020 |
Why?
|
| Age Factors | 2 | 2021 | 18460 | 0.020 |
Why?
|
| United States | 3 | 2022 | 70772 | 0.020 |
Why?
|
| Anxiety | 1 | 2023 | 4395 | 0.020 |
Why?
|
| Overweight | 1 | 2020 | 2393 | 0.020 |
Why?
|
| Prevalence | 2 | 2020 | 15404 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2022 | 53863 | 0.020 |
Why?
|
| Risk | 1 | 2019 | 9683 | 0.020 |
Why?
|
| Risk Factors | 3 | 2020 | 73094 | 0.020 |
Why?
|
| Depression | 1 | 2023 | 7876 | 0.010 |
Why?
|
| Hospitalization | 1 | 2023 | 10422 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15657 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2015 | 6037 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2023 | 41390 | 0.010 |
Why?
|
| Animals | 2 | 2023 | 169600 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 25454 | 0.010 |
Why?
|
| Mothers | 1 | 2010 | 2190 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23554 | 0.010 |
Why?
|
| Incidence | 1 | 2014 | 21146 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 13441 | 0.010 |
Why?
|
| Smoking | 1 | 2010 | 9030 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 40195 | 0.000 |
Why?
|
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_